IQVIA
Advancing Life Sciences with Data
Durham, North Carolina, United States
IQVIA was formed in 2016 through the acquisition and merger of IMS Health with Quintiles, later rebranded from QuintilesIMS in 2017. It is a global provider of advanced analytics, technology solutions, and clinical research services, employing approximately 93,000 people across 100+ countries and maintaining access to 1.2 billion non-identified patient records.
How We Help
Problem Statement
The problem IQVIA solves is the complexity and inefficiency in bringing new therapies to patients, addressing the need for data-driven insights, advanced technology, and streamlined clinical research within the life sciences industry.
Core Technology
Advanced analytics, AI-driven solutions, IQVIA Connected Intelligence™, cloud-based CRM application software, IQVIA CORE™, big data, generative AI for pharmacovigilance, machine learning
Key Differentiators
Extensive Data Assets (1.2 billion health records), Advanced Analytics and Technology Innovation (AI/ML for drug discovery, clinical trial optimization, personalized digital healthcare marketing), Global Reach and Infrastructure (operations in over 100 countries, 88,000-93,000 employees), Integrated Approach (end-to-end solutions throughout drug lifecycle), Real-World Evidence (RWE) Platforms, Strong Brand Reputation and Diverse Service Offerings, Strategic Partnerships (e.g., NVIDIA), Dedicated Biotech Focus.
Clinical Focus
Pioneering decentralized and patient-centric clinical trials, accelerating patient recruitment, expertise in biomarkers and antibody drug discovery, expediting new therapies for patients, improving data quality in clinical research.
Target Customers
Life sciences companies, pharmaceutical companies, biotech firms, healthcare providers, contract sales organizations.
Product Stage
Mature
Company Info
- Business Model
- B2B, SaaS, CRO (Contract Research Organization)
- Founded
- 2016
- Total Funding
- 1,740,000
- Website
- www.iqvia.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Operates as a Contract Research Organization (CRO) for clinical trials Phase I-IV, offering clinical pharmacology, post-approval services, regulatory affairs, and patient recruitment support for life sciences clients globally.
MedStartr Index Score
?What do you think of IQVIA?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.